Does PALBOCICLIB Cause Haematotoxicity? 144 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Haematotoxicity have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
144
Reports of Haematotoxicity with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
13
Deaths
9
Hospitalizations
How Dangerous Is Haematotoxicity From PALBOCICLIB?
Of the 144 reports, 13 (9.0%) resulted in death, 9 (6.3%) required hospitalization, and 10 (6.9%) were considered life-threatening.
Is Haematotoxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Haematotoxicity?
CYCLOPHOSPHAMIDE (1,410)
DOXORUBICIN (1,180)
VINCRISTINE (1,038)
RITUXIMAB (812)
CARBOPLATIN (803)
METHOTREXATE (799)
PREDNISONE (730)
CYTARABINE (701)
ETOPOSIDE (677)
CISPLATIN (668)
Which PALBOCICLIB Alternatives Have Lower Haematotoxicity Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID